This is a clinical trial for people who are at least 12 years old, have been diagnosed with alopecia areata and have lost at least 50% of the hair on their scalp.
The Allegro-100 clinical trial will determine if taking ritlecitinib at a dose of 100mg per day is safe, and if it can help more hair grow back. Ritlecitinib is currently FDA-approved at a dose of 50mg per day.
You may qualify to participate in this study if you:* • Are at least 12 years old • Have been diagnosed with alopecia areata and do not have hair loss caused by any other conditions • Have lost at least 50% of the hair on your scalp • Are in a current hair loss episode that has lasted 10 years or less
*There are additional requirements as determined by a screening process.
This study is taking place at locations throughout the United States.
More information on this trial is available at www.allegro100clinicaltrial.com.
